Wall Street brokerages expect Steris PLC (NYSE:STE) to post $663.43 million in sales for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Steris’ earnings. The highest sales estimate is $747.60 million and the lowest is $600.00 million. Steris posted sales of $696.80 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 4.8%. The business is scheduled to issue its next quarterly earnings report on Monday, August 3rd.

On average, analysts expect that Steris will report full-year sales of $3.04 billion for the current year, with estimates ranging from $2.94 billion to $3.21 billion. For the next year, analysts expect that the business will report sales of $3.19 billion, with estimates ranging from $3.12 billion to $3.27 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Steris.

Steris (NYSE:STE) last announced its quarterly earnings data on Wednesday, May 13th. The medical equipment provider reported $1.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.07. The business had revenue of $822.99 million for the quarter, compared to analyst estimates of $788.37 million. Steris had a return on equity of 16.34% and a net margin of 13.45%. During the same period in the prior year, the company earned $1.53 earnings per share.

A number of brokerages have recently commented on STE. Northcoast Research restated a “buy” rating on shares of Steris in a research note on Wednesday, February 12th. Stephens upped their target price on Steris from $145.00 to $170.00 and gave the stock an “overweight” rating in a research note on Friday, May 15th. Finally, Zacks Investment Research upgraded Steris from a “hold” rating to a “buy” rating and set a $174.00 target price on the stock in a research note on Friday, April 24th.

Shares of STE stock traded up $1.18 during mid-day trading on Wednesday, reaching $157.48. The stock had a trading volume of 432,030 shares, compared to its average volume of 666,777. Steris has a 1-year low of $105.69 and a 1-year high of $168.98. The company has a current ratio of 2.40, a quick ratio of 1.91 and a debt-to-equity ratio of 0.34. The firm has a market cap of $13.26 billion, a price-to-earnings ratio of 33.01 and a beta of 0.75. The business’s fifty day moving average is $148.59 and its 200-day moving average is $149.70.

The business also recently announced a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Friday, June 12th will be paid a $0.37 dividend. The ex-dividend date of this dividend is Thursday, June 11th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 0.94%. Steris’s payout ratio is 26.24%.

Hedge funds have recently modified their holdings of the business. Bay Harbor Wealth Management LLC purchased a new position in Steris during the first quarter worth approximately $29,000. Raab & Moskowitz Asset Management LLC purchased a new position in Steris during the fourth quarter worth approximately $32,000. Contravisory Investment Management Inc. purchased a new position in Steris during the first quarter worth approximately $30,000. CSat Investment Advisory L.P. purchased a new position in Steris during the fourth quarter worth approximately $33,000. Finally, Tobias Financial Advisors Inc. purchased a new position in Steris during the fourth quarter worth approximately $38,000. Institutional investors own 90.51% of the company’s stock.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Read More: Penny Stocks, What You Need To Know

Get a free copy of the Zacks research report on Steris (STE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.